Clinical trials
Lymphoma, Large B-Cell, Diffuse trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Peking University Cancer Hospital & Institute | 2 |
| Centre Antoine Lacassagne | 1 |
| Chinese PLA General Hospital | 1 |
| Hebei Medical University Fourth Hospital | 1 |
| Ruijin Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| The Catholic University of Korea | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Lymphoma | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Prolymphocytic | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Blast Crisis | 1 |
| Carcinoma, Renal Cell | 1 |
| Congenital Abnormalities | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.